INDV
Price
$24.07
Change
+$0.35 (+1.48%)
Updated
Oct 8 closing price
Capitalization
3B
14 days until earnings call
KSPHF
Price
$30.28
Change
+$3.15 (+11.61%)
Updated
Aug 6 closing price
Capitalization
1.18B
Interact to see
Advertisement

INDV vs KSPHF

Header iconINDV vs KSPHF Comparison
Open Charts INDV vs KSPHFBanner chart's image
Indivior
Price$24.07
Change+$0.35 (+1.48%)
Volume$1.5M
Capitalization3B
Kissei Pharmaceutical
Price$30.28
Change+$3.15 (+11.61%)
Volume$100
Capitalization1.18B
INDV vs KSPHF Comparison Chart in %
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INDV vs. KSPHF commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDV is a Buy and KSPHF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (INDV: $24.07 vs. KSPHF: $30.28)
Brand notoriety: INDV and KSPHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INDV: 64% vs. KSPHF: 100%
Market capitalization -- INDV: $3B vs. KSPHF: $1.18B
INDV [@Pharmaceuticals: Generic] is valued at $3B. KSPHF’s [@Pharmaceuticals: Generic] market capitalization is $1.18B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDV’s FA Score shows that 0 FA rating(s) are green whileKSPHF’s FA Score has 3 green FA rating(s).

  • INDV’s FA Score: 0 green, 5 red.
  • KSPHF’s FA Score: 3 green, 2 red.
According to our system of comparison, KSPHF is a better buy in the long-term than INDV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDV’s TA Score shows that 5 TA indicator(s) are bullish while KSPHF’s TA Score has 1 bullish TA indicator(s).

  • INDV’s TA Score: 5 bullish, 3 bearish.
  • KSPHF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, INDV is a better buy in the short-term than KSPHF.

Price Growth

INDV (@Pharmaceuticals: Generic) experienced а +2.60% price change this week, while KSPHF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.16%. For the same industry, the average monthly price growth was +5.42%, and the average quarterly price growth was +62.58%.

Reported Earning Dates

INDV is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($3B) has a higher market cap than KSPHF($1.18B). INDV has higher P/E ratio than KSPHF: INDV (29.72) vs KSPHF (16.60). INDV YTD gains are higher at: 93.644 vs. KSPHF (21.120). KSPHF has higher annual earnings (EBITDA): 18.6B vs. INDV (261M). KSPHF has more cash in the bank: 50B vs. INDV (510M). INDV has less debt than KSPHF: INDV (366M) vs KSPHF (1.26B). KSPHF has higher revenues than INDV: KSPHF (81.1B) vs INDV (1.17B).
INDVKSPHFINDV / KSPHF
Capitalization3B1.18B256%
EBITDA261M18.6B1%
Gain YTD93.64421.120443%
P/E Ratio29.7216.60179%
Revenue1.17B81.1B1%
Total Cash510M50B1%
Total Debt366M1.26B29%
FUNDAMENTALS RATINGS
INDV vs KSPHF: Fundamental Ratings
INDV
KSPHF
OUTLOOK RATING
1..100
5244
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
4828
SMR RATING
1..100
6284
PRICE GROWTH RATING
1..100
3748
P/E GROWTH RATING
1..100
10031
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KSPHF's Valuation (15) in the null industry is significantly better than the same rating for INDV (93). This means that KSPHF’s stock grew significantly faster than INDV’s over the last 12 months.

KSPHF's Profit vs Risk Rating (28) in the null industry is in the same range as INDV (48). This means that KSPHF’s stock grew similarly to INDV’s over the last 12 months.

INDV's SMR Rating (62) in the null industry is in the same range as KSPHF (84). This means that INDV’s stock grew similarly to KSPHF’s over the last 12 months.

INDV's Price Growth Rating (37) in the null industry is in the same range as KSPHF (48). This means that INDV’s stock grew similarly to KSPHF’s over the last 12 months.

KSPHF's P/E Growth Rating (31) in the null industry is significantly better than the same rating for INDV (100). This means that KSPHF’s stock grew significantly faster than INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDVKSPHF
RSI
ODDS (%)
Bearish Trend 1 day ago
60%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
55%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
24%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
23%
Advances
ODDS (%)
Bullish Trend 1 day ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
72%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMRYX17.25N/A
N/A
VanEck Emerging Markets Y
ZVGIX62.15N/A
N/A
Zevenbergen Genea Institutional
FGLGX26.65N/A
N/A
Fidelity Series Large Cap Stock
GAOSX22.47N/A
N/A
JPMorgan Global Allocation I
RMQHX694.21N/A
N/A
Rydex Monthly Rbl NASDAQ-100® 2x Strt H

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and CAIHF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and CAIHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+1.48%
CAIHF - INDV
27%
Poorly correlated
N/A
ASRT - INDV
26%
Poorly correlated
+0.21%
ALKS - INDV
25%
Poorly correlated
+1.81%
MKKGY - INDV
24%
Poorly correlated
+1.30%
DRRX - INDV
24%
Poorly correlated
N/A
More

KSPHF and

Correlation & Price change

A.I.dvisor tells us that KSPHF and LVRLF have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KSPHF and LVRLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KSPHF
1D Price
Change %
KSPHF100%
N/A
LVRLF - KSPHF
5%
Poorly correlated
N/A
INDV - KSPHF
1%
Poorly correlated
+1.48%
MILFF - KSPHF
1%
Poorly correlated
+34.24%
HSTI - KSPHF
1%
Poorly correlated
N/A
HTSUF - KSPHF
0%
Poorly correlated
N/A
More